Early stage biotech company focused on commercialization of dry-eye treatment, and orphan drug for systemic sclerosis.
Employees: 11-50
Investors 1
| Date | Name | Website |
| - | Innova Mem... | innovamemp... |
Mentions in press and media 1
| Date | Title | Description |
| 10.07.2007 | ArGentis Pharma raises $1M for dry-eye treatment | ArGentis Pharmaceuticals, a Memphis-based specialty pharmaceutical company, raised $1 million of a projected $2 million first funding round, VentureWire reports (subscription required). The company is developing testosterone- and progestero... |